ABT is forming a perfect cup and handle patternNYSE:ABT is looking bullish and has a long term target of 192$, being a long term trade, I will place my stop at 115$ (weekly close).
PS. My view only not financial advice!
Abbott Laboratories
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.55 B EUR
37.74 B EUR
1.73 B
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
IPO date
Mar 1, 1937
Identifiers
3
ISIN US0028241000
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Related stocks
On the long-term (10-year) supportThe price corrects significantly following the quarterly earnings report and drops until it reaches the long-term support highlighted in blue, where the price halts its decline.
A rebound from this support level is very likely, as it has been providing support for the price for the past 10 years.
Ford Robert B Insider BUY ABT P/E (TTM) ~28.3x - 28.9x HIGH ⚠️. Despite the price drop, the market values it highly.
Forward P/E ~18.5x - 19.1x GOOD ✅. It is at a 5-year low on this metric.
Free Cash Flow ~$6.5 billion EXCELLENT ✅. Cash generating machine.
ROE ~17.6% EXCELLENT ✅. Meets your 14.5% criterion.
Debt/Equity ~0.23 (
Earnings Tension Trade: Why AI Is Betting on ABT UpsidABT Earnings Signal | 2026-01-21
Direction: BUY CALLS
Strike: $117.00
Expiry: Jan 23, 2026
Entry: ~$4.85
Target: $6.50 (+34%)
Extended Target: $7.50 (+55%)
Stop Loss: $3.88 (-20%)
🧠 Why This Trade
Katy AI Forecast: Bullish price path toward $123+ despite neutral label
Technical Setup: Deep
ABT long ideaABT is the stock ticker for Abbott Laboratories, a global healthcare company that develops and sells a wide range of health products. Its business is divided into four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company's pr
$ABT Call Alert – Oct 31 ’25 $135 Calls | 34% ROI PotentialEnter: NYSE:ABT OCT 31 2025 $135 CALLS
Buy in Price: $2.75 - $3.35
Take Profit: $3.69
Stop Bleeding: $2.42
ROI Potential: 34%
Exit Within: 132 Minutes
ABT (Abbott Laboratories) - Long SetupTrading Idea: NYSE:ABT (Abbott Laboratories) - Long Setup
🎯 Idea: LONG
⏰ Timeframe: Daily
📊 Pattern: Bullish Breakout from Consolidation
Fundamental Context:
Fundamental Score: 5/9 (Neutral).
Business: Global Healthcare Leader (Medical Devices, Diagnostics, Nutrition).
Growth: Weak Revenue + S
ABT - Possible break out Hello everyone,
This is the last one for today.
ABT Abbott Laboratories .
What they do?
Abbott Laboratories offers pharmaceutical, diagnostic, and nutritional products, as well as medical devices to treat cardiovascular disease and diabetes care products. Operating internationally, the company wa
ABT Buy/LongTechnical analysis of the company. According to financial indicators, the company is currently undervalued and is supported by SMA200. The target price for the company is $142.
ABT Long TradeVAH retest long here or another pullback close to POC
Good Risk to reward on a solid company
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
A
XS207615510
Abbott Ireland Financing DAC 0.375% 19-NOV-2027Yield to maturity
2.39%
Maturity date
Nov 19, 2027
See all ABL bonds
Frequently Asked Questions
The current price of ABL is 92.00 EUR — it has increased by 3.78% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Abbott Laboratories stocks are traded under the ticker ABL.
ABL stock has fallen by −0.65% compared to the previous week, the month change is a −12.80% fall, over the last year Abbott Laboratories has showed a −24.52% decrease.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABL price has a max estimate of 141.19 EUR and a min estimate of 94.41 EUR. Watch ABL chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABL stock is 3.85% volatile and has beta coefficient of 0.35. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of 158.78 B, it has decreased by −12.97% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Apr 22, 2026. Keep track of upcoming events with our Earnings Calendar.
ABL earnings for the last quarter are 1.28 EUR per share, whereas the estimation was 1.27 EUR resulting in a 0.29% surprise. The estimated earnings for the next quarter are 0.96 EUR per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to 9.76 B EUR, despite the estimated figure of 10.05 B EUR. In the next quarter, revenue is expected to reach 9.19 B EUR.
ABL net income for the last quarter is 1.51 B EUR, while the quarter before that showed 1.36 B EUR of net income which accounts for 10.90% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABL dividends are paid quarterly. The last dividend per share was 0.54 EUR. As of today, Dividend Yield (TTM)% is 2.20%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.92% in 2025, and payout ratio reached 64.34%. The year before the numbers were 1.98% and 29.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, ABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the sell signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.